24-Hour Intragastric Acidity and Plasma Gastrin during Long-Term Treatment with Omeprazole or Ranitidine in Patients with Reflux Esophagitis

References

• Lindberg P, Nordberg P, Alminger T, et al. The mechanism of action of the gastric acid secretion inhibitor omeprazole. J Med Chem 1986; 29: 1327–1329
   PubMed Web of Science ®Google Scholar
• Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L. Effect of omeprazole—a gastric proton pump inhibitor—on pentagastrin stimulated acid secretion in man. Gut 1983; 24: 270–276
   PubMed Web of Science ®Google Scholar
• Lind T, Cederberg C, Ekenved G, Olbe L. Inhibition of basal and betazoleand sham‐feeding induced acid secretion by omeprazole in man. Scand J Gastroenterol 1986; 21: 1004–1010
   PubMed Web of Science ®Google Scholar
• Bardhan K D, Bianchi‐Porro G, Bose K, et al. A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol 1986; 8: 408–413
   PubMed Web of Science ®Google Scholar
• Walan A, Bader J P, Klassen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989; 320: 69–75
   PubMed Web of Science ®Google Scholar
• Klinkenberg‐Knol E C, Jansen J B M J, Festen H P M, et al. Double‐blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux esophagitis. Lancet 1987; 1: 349–351
   PubMed Web of Science ®Google Scholar
• Lamers C B H W, Lind T, Moberg S, et al. Omeprazole in Zollinger‐Ellison syndrome. N Engl J Med 1984; 310: 758–761
   PubMed Web of Science ®Google Scholar
• Walsh J H, Richardson C T, Fordtran J S. pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 1975; 55: 462–468
   PubMed Web of Science ®Google Scholar
• Mahachai V, Walker K, Thomson B R. Comparison of cimetidine and ranitidine on 24‐hour intragastric acidity and serum gastrin profile in patients with esophagitis. Dig Dis Sci 1985; 30: 321–328
   PubMed Web of Science ®Google Scholar
• Brunner G, Creutzfeldt W, Starky Y, Lamberts R. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high‐dose ranitidine treatment. Digestion 1988; 39: 80–90
   PubMed Web of Science ®Google Scholar
• Lanzon‐Miller S, Pounder R E, Hamilton M R, et al. Twenty‐four‐hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1987; 1: 239–251
   PubMedGoogle Scholar
• Lanzon‐Miller S, Pounder R E, Hamilton M R, et al. Twenty‐four‐hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia. Aliment Pharmacol Ther 1987; 1: 225–237
   PubMedGoogle Scholar
• Lind T, Cederberg C, Olausson M, Olbe L. 24‐hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients. Gastroenterology 1990; 99: 1593–1598
   PubMedGoogle Scholar
• Tytgat O N, Nio C Y. The medical therapy of reflux esophagitis. Baillière's Clin Gastroenterol 1987; 1: 791–807
   PubMedGoogle Scholar
• Johnson N J, Miles J G, Wood J R. Acute treatment of reflux esophagitis: a multi‐centre trial comparing ranitidine 150 mg bid with 300 mg qid. Gastroenterology 1989; 96: 176A
   Google Scholar
• Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux eosophagitis. Results of a double‐blind, randomized, Scandinavian multicentre study. Scand J Gastroenterol 1988; 23: 625–632
   PubMed Web of Science ®Google Scholar
• Lundell L, Backman L, Ekström P, et al. Omeprazole or high‐dose ranitidine in the treatment of patients with reflux oesophagitis not responding to ‘standard doses’ of H2‐receptor antagonists. Aliment Pharmacol Ther 1990; 4: 145–155
   PubMed Web of Science ®Google Scholar
• Rowland M, Tozer T N. Clinical pharmacokinetics. Lea & Febiger, Philadelphia 1980
   Google Scholar
• Lundell L, Backman L, Ekström P, et al. Prevention of relapse of esophagitis after endoscopic healing: the efficacy of omeprazole compared with ranitidine. Gastroenterology 1990; 98: 1484A
   Google Scholar
• Ruth M, Ehnbom H, Lundell L, Lönroth H, Sandberg N, Sandmark S. The effect of omeprazole or ranitidine treatment on 24‐hour esophageal acidity in patients with reflux esophagitis. Scand J Gastroenterol 1988; 23: 1141–1146
   PubMed Web of Science ®Google Scholar
• Johnson L F, Demeester T R, Haggit R C. Esophageal response to gastroesophageal reflux. A quantitative study. Dig Dis Sci 1978; 23: 498–509
   Web of Science ®Google Scholar
• de Caestecker J S, Blackwell J N, Pryde A, Heading R C. Daytime gastro‐oesophageal reflux is important in oesophagitis. Gut 1987; 28: 519–526
   PubMed Web of Science ®Google Scholar
• Hetzel E J, Dent J, Reed W D, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903–912
   PubMed Web of Science ®Google Scholar
• Crean G P, Marshall H W, Ramsey R D E. Parietal cell hyperplasia induced by administration of pentagastrin (IC50, 123) to rats. Gastroenterology 1959; 517: 147–155
   Google Scholar
• Nwokolo C U, Gavey C J, Smith J T L, Sawyerr A, Pounder R E. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine. Gut 1989; 30: 1487A
   Google Scholar
• Rogers M J, Primrose J N, Holmfield J, Johnston D. Tolerance' to H2 receptor antagonists: does it occur and by what mechanism?. Gut 1989; 30: 1489A
   Google Scholar
• Lichtenberger L M, Nelson A A, Graziani L A. Amine trapping: physical explanation for the inhibitory effect of gastric acidity on the post‐prandial release of gastrin. Gastroenterology 1986; 90: 1223–1231
   PubMed Web of Science ®Google Scholar